Psychiatry and Neurology, Neurology · Dickson, TN
NPI
1386608149
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
127 Crestview Park Dr Ste 200
Dickson, TN, 37055
Phone (615) 441-4520
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
3,450 services
Medicare patients, 2024
354
Average age 73
Drug cost, 2024
$1.3M
4,798 prescriptions
Company payments, 2025
$2,118
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Enawgaw B Mehari was code J1010 (injection, methylprednisolone acetate, 1 mg), 842 times for 18 patients. In total Enawgaw B Mehari billed 3,450 services in 89 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 842 | 18 | $0.10 | $87.82 |
| 99214 Office E&M - Established | Office | 492 | 222 | $83.94 | $41K |
| 95886 Electrical Nerve Conductivity | Office | 193 | 82 | $68.97 | $13K |
| 36415 Venipuncture Blood Collection | Office | 153 | 134 | $8.61 | $1,317 |
| 82607 Clinical Chemistry | Office | 135 | 126 | $14.70 | $1,985 |
| 99204 Office E&M - New | Office | 102 | 102 | $111.84 | $11K |
| 82746 Clinical Chemistry | Office | 92 | 90 | $14.41 | $1,326 |
| 84443 Clinical Chemistry | Office | 87 | 85 | $16.46 | $1,432 |
| 95819 Neurologic | Office | 58 | 57 | $300.16 | $17K |
| 99222 Hospital E&M - Initial | Facility | 45 | 43 | $84.93 | $3,822 |
| 95913 Electrical Nerve Conductivity | Office | 41 | 41 | $199.92 | $8,197 |
| 95911 Electrical Nerve Conductivity | Office | 40 | 40 | $146.61 | $5,864 |
| 82565 Clinical Chemistry | Office | 39 | 38 | $5.02 | $196 |
| 85652 Clinical Chemistry | Office | 39 | 38 | $2.65 | $103 |
| 96372 Injection Administration | Office | 37 | 34 | $10.42 | $386 |
By year: 2022 $143K for 3,413 services; 2023 $164K for 3,458 services; 2024 $143K for 3,450 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 153 | 134 | $8.61 | $1,317 |
| 82607 Clinical Chemistry | 135 | 126 | $14.70 | $1,985 |
| 82746 Clinical Chemistry | 92 | 90 | $14.41 | $1,326 |
| 84443 Clinical Chemistry | 87 | 85 | $16.46 | $1,432 |
| 85652 Clinical Chemistry | 39 | 38 | $2.65 | $103 |
| 82565 Clinical Chemistry | 39 | 38 | $5.02 | $196 |
| 84520 Clinical Chemistry | 34 | 33 | $3.87 | $132 |
| 83540 Clinical Chemistry | 26 | 26 | $6.34 | $165 |
Medicare prescription drug claims, 2024
In 2024, the drug Enawgaw B Mehari prescribed most often to Medicare patients was Gabapentin, with 488 prescriptions and refills. In total Enawgaw B Mehari wrote 4,798 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 488 | 526 | 114 | $4,474 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 315 | 492 | 73 | $4,831 |
| Qulipta Atogepant | 314 | 333 | 70 | $363K |
| Oxcarbazepine Generic | 285 | 405 | 82 | $8,581 |
| Levetiracetam Generic | 227 | 322 | 46 | $4,351 |
| Topiramate Generic | 227 | 370 | 52 | $1,164 |
| Duloxetine Hcl Generic | 204 | 338 | 50 | $3,457 |
| Nurtec Odt Rimegepant Sulfate | 176 | 176 | 51 | $228K |
| Ubrelvy Ubrogepant | 163 | 165 | 33 | $179K |
| Donepezil Hcl Generic | 162 | 260 | 43 | $1,227 |
| Sertraline Hcl Generic | 149 | 203 | 30 | $793 |
| Escitalopram Oxalate Generic | 134 | 223 | 44 | $1,038 |
| Pregabalin Generic | 125 | 151 | 21 | $2,317 |
| Quetiapine Fumarate Generic | 117 | 166 | 27 | $804 |
| Primidone Generic | 112 | 203 | 24 | $2,113 |
Brand drugs: 877 claims; generic drugs: 3,910 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Enawgaw B Mehari $2,118 ($2,118 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $440.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $440 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $172 |
| Lundbeck LLC | 7 | $147 |
| Pfizer Inc. PFE | 10 | $138 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $132 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $121 |
| Argenx US, Inc. ARGX | 5 | $114 |
| Axsome Therapeutics, Inc. AXSM | 4 | $110 |
| Aucta Pharmaceuticals, Inc. | 5 | $90.49 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $82.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.